Chemical Component Summary | |
---|---|
Name | Tedizolid |
Synonyms | torezolid; Sivextro, TR-700 |
Identifiers | (5~{R})-3-[3-fluoranyl-4-[6-(2-methyl-1,2,3,4-tetrazol-5-yl)pyridin-3-yl]phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one |
Formula | C17 H15 F N6 O3 |
Molecular Weight | 370.338 |
Type | NON-POLYMER |
Isomeric SMILES | Cn1nc(nn1)c2ccc(cn2)c3ccc(cc3F)N4C[C@@H](OC4=O)CO |
InChI | InChI=1S/C17H15FN6O3/c1-23-21-16(20-22-23)15-5-2-10(7-19-15)13-4-3-11(6-14(13)18)24-8-12(9-25)27-17(24)26/h2-7,12,25H,8-9H2,1H3/t12-/m1/s1 |
InChIKey | XFALPSLJIHVRKE-GFCCVEGCSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 42 |
Chiral Atom Count | 1 |
Bond Count | 45 |
Aromatic Bond Count | 17 |
Drug Info: DrugBank
DrugBank ID | DB14569 |
---|---|
Name | Tedizolid |
Groups |
|
Description | Drug-resistant bacteria, such as methicillin-resistant _Staphylococcus aureus_, vancomycin-resistant _Enterococcus faecium_, and penicillin-resistant _Streptococcus penumoniae_, represent a massive public health threat.[A199086, A199131] Tedizolid is a member of the oxazolidinone class of antibiotics, which includes the previously approved [linezolid] and is generally effective against multidrug-resistant Gram-positive bacteria. Tedizolid is indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and is generally more effective and more tolerable than [linezolid].[L11232, A199086, A199050] Tedizolid was approved by the FDA on June 20, 2014, for sale by Cubist Pharmaceuticals as tedizolid phosphate (SIVEXTRO®). This product is currently available as both an oral tablet and as a powder for intravenous injection.[L11232] |
Synonyms |
|
Indication | Tedizolid is indicated for the treatment of acute bacterial infections of the skin and skin structure (ABSSSI). To prevent drug resistance, tedizolid should only be used for infections that are caused by susceptible bacteria.[L11232] |
Categories |
|
ATC-Code | J01XX11 |
CAS number | 856866-72-3 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
23S ribosomal RNA | - | unknown | inhibitor |
Amine oxidase [flavin-containing] A | MENQEKASIAGHMFDVVVIGGGISGLSAAKLLTEYGVSVLVLEARDRVGG... | unknown | inhibitor |
Amine oxidase [flavin-containing] B | MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQK... | unknown | inhibitor |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 11234049 |
ChEMBL | CHEMBL1257051 |
ChEBI | CHEBI:82717 |
CCDC/CSD | ZOVQOT |